External Infusion Pumps
National · Effective Jan 25, 2026
6 active Medicare policies list J1551, and 19 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
National · Effective Jan 25, 2026
J9 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JL · Effective Jul 1, 2026
J9 · Effective Jul 1, 2026
19 policies from 11 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J1551 |
|---|---|---|
| Subcutaneous Immune Globulins (Cutaquig, Cuvitru, Gammagard Liquid, Gammagard Liquid ERC, Gammaked, Gamunex-C, Hizentra, HyQvia, Xembify) | Not recorded | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Subcutaneous Immune Globulins (Cutaquig, Cuvitru, Gammagard Liquid, Gammaked, Gamunex-C, Hizentra, HyQvia, Xembify)Effective 12/01/2025 - 04/30/2026 | Dec 1, 2025 | Prior auth requiredInferred from policy title |
| Subcutaneous Immune Globulins (Cutaquig, Cuvitru, Hizentra, HyQvia, Xembify, Gammagard Liquid, Gammaked, Gamunex-C)Effective 12/01/2024 - 11/30/2025 | Dec 1, 2024 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Policy | Effective | Status of J1551 |
|---|---|---|
| Immunoglobulin Therapy | Jan 1, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J1551 |
|---|---|---|
| Immunoglobulin Therapy | Jan 1, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J1551 |
|---|---|---|
| Immunoglobulin Therapy | Jan 1, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J1551 |
|---|---|---|
| Immunoglobulin Therapy | Jan 1, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J1551 |
|---|---|---|
| Immune Globulin (IVIG and SCIG) | Oct 1, 2026 | Covered |
| Provider Administered Drugs – Site of Care | Oct 1, 2026 | Covered |
| Policy | Effective | Status of J1551 |
|---|---|---|
| Immune Globulin (IVIG and SCIG) | Oct 1, 2026 | Covered |
| Provider Administered Drugs – Site of Care | Oct 1, 2026 | Covered |
| Policy | Effective | Status of J1551 |
|---|---|---|
| SCIG (Immune Globulin SQ): Hizentra, Hyqvia, Cuvitru, Cutaquig, Xembify | Dec 1, 2016 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1551 |
|---|---|---|
| Immune Globulin Subcutaneous (Hizentra, Gammagard Liquid, Gamunex-C/Gammaked, HyQvia, Cuvitru, Cutaquig, and Xembify for Subcutaneous Administration) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1551 |
|---|---|---|
| SCIG (immune globulin SQ): Hizentra, Gammagard Liquid, Gamunex-C, Gammaked, HyQvia, Cuvitru, Cutaquig, Xembify | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1551 |
|---|---|---|
| Immune Globulin (IVIG and SCIG) | Oct 1, 2026 | Covered |